Status:
TERMINATED
Catheter Ablation as the First Line Therapy for Typical Atrial Flutter
Lead Sponsor:
University Hospital, Rouen
Conditions:
Atrial Flutter
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Catheter ablation of typical atrial flutter is a well established technique with a high acute success rate and very low complication and recurrence rates. It has also been shown that ablation of recur...
Eligibility Criteria
Inclusion
- first episode of symptomatic typical atrial flutter
- \> 18 years old
Exclusion
- Prior antiarrhythmic drug treatment for atrial flutter
- History of cavotricuspid isthmus ablation
- Pregnancy
- Hyperthyroidism
- contraindication for anticoagulant therapy
- Life expectancy \< 1 year
- contraindication to catheter ablation or to electrical cardioversion
Key Trial Info
Start Date :
June 1 2001
Trial Type :
INTERVENTIONAL
End Date :
January 1 2007
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT00213408
Start Date
June 1 2001
End Date
January 1 2007
Last Update
June 18 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Rouen
Rouen, Seine Maritime, France, 76031